Complex roles of the old drug aspirin in cancer chemoprevention and therapy
H Hua, H Zhang, Q Kong, J Wang… - Medicinal research …, 2019 - Wiley Online Library
The nonsteroidal anti‐inflammatory agent aspirin is widely used for preventing and treating
cardiovascular and cerebrovascular diseases. In addition, epidemiologic evidences reveal …
cardiovascular and cerebrovascular diseases. In addition, epidemiologic evidences reveal …
Surface receptor‐mediated targeted drug delivery systems for enhanced cancer treatment: A state‐of‐the‐art review
S Kunjiappan, P Pavadai, S Vellaichamy… - Drug Development …, 2021 - Wiley Online Library
Enhanced cancer treatment remains as one of the focused areas for researchers around the
world. Hence, the progress in this direction will be a challenge and an opportunity in, inter …
world. Hence, the progress in this direction will be a challenge and an opportunity in, inter …
Nanomedicine to overcome multidrug resistance mechanisms in colon and pancreatic cancer: recent progress
Simple Summary The cellular mechanisms of drug resistance prevent the correct efficacy of
the therapies used in various types of cancer and nanotechnology has been postulated as a …
the therapies used in various types of cancer and nanotechnology has been postulated as a …
The inhibition of ABCB1/MDR1 or ABCG2/BCRP enables doxorubicin to eliminate liver cancer stem cells
Two ATP-binding cassette transporters, ABCB1/MDR1 and ABCG2/BCRP, are considered
the most critical determinants for chemoresistance in hepatocellular carcinoma. However …
the most critical determinants for chemoresistance in hepatocellular carcinoma. However …
Secosteroid–quinoline hybrids as new anticancer agents
AI Ilovaisky, AM Scherbakov, VM Merkulova… - The Journal of steroid …, 2023 - Elsevier
An elegant approach to unknown secosteroid–quinoline hybrids is disclosed. A series of 13,
17-secoestra-1, 3, 5 (10)-trien-17-oic acid [N′-(iso) quinolylmethylene] hydrazides was …
17-secoestra-1, 3, 5 (10)-trien-17-oic acid [N′-(iso) quinolylmethylene] hydrazides was …
[HTML][HTML] MicroRNAs modulate drug resistance-related mechanisms in hepatocellular carcinoma
Y Liang, Q Liang, L Qiao, F Xiao - Frontiers in Oncology, 2020 - frontiersin.org
Primary liver cancer [hepatocellular carcinoma (HCC)] is one of the most common malignant
tumors worldwide, causing serious health threats because of its high morbidity and mortality …
tumors worldwide, causing serious health threats because of its high morbidity and mortality …
TGF‐β1 elevates P‐gp and BCRP in hepatocellular carcinoma through HOTAIR/miR‐145 axis
J Kong, Y Qiu, Y Li, H Zhang… - Biopharmaceutics & Drug …, 2019 - Wiley Online Library
Multidrug resistance (MDR) is common in patients and has been linked to transforming
growth factor‐β1 (TGF‐β1) and overexpression of drug efflux transporters P‐glycoprotein (P …
growth factor‐β1 (TGF‐β1) and overexpression of drug efflux transporters P‐glycoprotein (P …
FOXC2 promotes oxaliplatin resistance by inducing epithelial-mesenchymal transition via MAPK/ERK signaling in colorectal cancer
Background Chemoresistance is a major obstacle to improving the survival rate of colorectal
cancer (CRC) patients. Forkhead box protein C2 (FOXC2), a member of the forkhead box …
cancer (CRC) patients. Forkhead box protein C2 (FOXC2), a member of the forkhead box …
Ginsenoside Rb1 for overcoming cisplatin-insensitivity of A549/DDP cells in vitro and vivo through the dual-inhibition on two efflux pumps of ABCB1 and PTCH1
X Niu, Y Shi, Q Li, H Chen, X Fan, Y Yu, C Lv, J Lu - Phytomedicine, 2023 - Elsevier
Background The multi-drug resistance is an inherent weakness in the chemotherapeutics of
non-small cell lung cancer occurring frequently all over the world. Clinically, ginseng and …
non-small cell lung cancer occurring frequently all over the world. Clinically, ginseng and …
Role of sirtuins in hepatocellular carcinoma progression and multidrug resistance: mechanistical and pharmacological perspectives
MP Ceballos, AD Quiroga, NF Palma - Biochemical Pharmacology, 2023 - Elsevier
Hepatocellular carcinoma (HCC) is the third most common cause of death from cancer
worldwide. Therapeutic strategies are still challenging due to the high relapse rate after …
worldwide. Therapeutic strategies are still challenging due to the high relapse rate after …